MYRRH WOMAN- menthol pill 
MIR BIOTECHNOLOGY

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

menthol

sodium sulfate, niacinamide, olive leaf, adenosine, etc

Cold odor Trichomonas candida infection treatment

Lack of come secretion

Vaginal cold urinary incontinence

Insensitivity to orgasms

Dry, rub and scar of Y zone

Lack of vaginal elasticity

Menopausal hormone imbalance

Lack of libido

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight

2. Do not use on open wounds, eczema, and other irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

Keep out of reach of children.

Wash the Y zone thoroughly, then put the Woman Essence in a pill and put it deeply into the vagina
After 7 days, it is steadily used for 2 ~ 3 days for 4 months.

for vaginal use only

label

MYRRH WOMAN 
menthol pill
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72263-0002
Route of AdministrationVAGINAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL0.5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ADENOSINE (UNII: K72T3FS567)  
NIACINAMIDE (UNII: 25X51I8RD4)  
Product Characteristics
ColorgrayScoreno score
ShapeROUNDSize10mm
FlavorMENTHOLImprint Code none
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72263-0002-14 g in 1 BOTTLE; Type 0: Not a Combination Product04/27/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other04/27/2018
Labeler - MIR BIOTECHNOLOGY (694203851)
Registrant - MIR BIOTECHNOLOGY (694203851)
Establishment
NameAddressID/FEIBusiness Operations
MIR BIOTECHNOLOGY694203851manufacture(72263-0002)

Revised: 4/2018
Document Id: 6acabf35-a427-bcb3-e053-2991aa0a6f38
Set id: 6acabf35-a426-bcb3-e053-2991aa0a6f38
Version: 1
Effective Time: 20180426
 
MIR BIOTECHNOLOGY